Underlying disease | adjusted | Drug group | adjusted | ||
---|---|---|---|---|---|
OR (CI) | P-value | OR (CI) | P-value | ||
Dementia | 10.6(1.2-93.9) | 0.034 | Anti-diabetics | 0.5(0.1-2.3) | 0.152 |
Diabetes | 2.6(6.9-7.0) | 0.072 | Anti-hypertensive | 0.7(0.1-3.7) | 0.432 |
Hypertension | 1.1(3.0-5.3) | 0.843 | Diuretics | 0.4(0.1-1.3) | 0.124 |
Hyperlipidemia | – | – | Antibiotics | 2.3(0.5-9.8) | 0.086 |
Cardiovascular disease | 0.9(1.2-3.0) | 0.874 | Anti-hyperlipidemics | 0.6(0.1-2.8) | 0.361 |
Kidney disease | 1.1(2.2-6.0) | 0.951 | Analgesics | 1.4(0.3-5.6) | 0.463 |
Liver disease | – | – | Anti-coagulants | 0.3(0.0-1.9) | 0.029 |
Neurologic disease | 8.1(6.1-31.2) | 0.002 | Chemotherapy | 0.2(0.1-3.2) | 0.078 |
Malignancies | 3.3(8.0-10.1) | 0.048 | Anti-convulsant | 0.2(0.1-3.2) | 0.078 |
Lung disease | 1.4(7.2-12.0) | 0.737 | Sedatives | 2.1(0.16-3.5) | 0.481 |
Infectious disease | 1.2(5.9-15.0) | 0.899 | Opioids | 0.9 | 0.861 |